Literature DB >> 16538703

Comparing two crossing hazard rates by Cox proportional hazards modelling.

Kejian Liu1, Peihua Qiu, Jun Sheng.   

Abstract

Motivated by a clinical trial of zinc nasal spray for the treatment of the common cold, we consider the problem of comparing two crossing hazard rates. A comprehensive review of the existing methods for dealing with the crossing hazard rates problem is provided. A new method, based on modelling the crossing hazard rates, is proposed and implemented under the Cox proportional hazards framework. The main advantage of the proposed method is the utilization of the Box-Cox transformation which covers a wide range of hazard crossing patterns. Simulation studies are conducted for comparing the performance of the existing methods and the proposed one, which show that the proposed method outperforms some of its peers in certain cases. Applications to a kidney dialysis patients data and the zinc nasal spray clinical trial data are discussed. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16538703     DOI: 10.1002/sim.2544

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Confidence intervals for the first crossing point of two hazard functions.

Authors:  Ming-Yen Cheng; Peihua Qiu; Xianming Tan; Dongsheng Tu
Journal:  Lifetime Data Anal       Date:  2009-11-01       Impact factor: 1.588

2.  Evaluation of the treatment time-lag effect for survival data.

Authors:  Kayoung Park; Peihua Qiu
Journal:  Lifetime Data Anal       Date:  2017-01-28       Impact factor: 1.588

3.  Partitioned log-rank tests for the overall homogeneity of hazard rate functions.

Authors:  Yukun Liu; Guosheng Yin
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

4.  Comparison of multiple hazard rate functions.

Authors:  Zhongxue Chen; Hanwen Huang; Peihua Qiu
Journal:  Biometrics       Date:  2015-09-22       Impact factor: 2.571

5.  Crossing Hazard Functions in Common Survival Models.

Authors:  Jiajia Zhang; Yingwei Peng
Journal:  Stat Probab Lett       Date:  2009-10-15       Impact factor: 0.870

6.  Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation.

Authors:  Frank Peinemann; Elvira C van Dalen; Heike Enk; Godelieve Am Tytgat
Journal:  Cochrane Database Syst Rev       Date:  2019-04-24

7.  Statistical inference methods for two crossing survival curves: a comparison of methods.

Authors:  Huimin Li; Dong Han; Yawen Hou; Huilin Chen; Zheng Chen
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

8.  Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.

Authors:  Helen C Stankiewicz Karita; Kirsten Hauge; Amalia Magaret; Constance Mao; Jeffrey Schouten; Verena Grieco; Long Fu Xi; Denise A Galloway; Margaret M Madeleine; Anna Wald
Journal:  JAMA Netw Open       Date:  2019-04-05

9.  A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature.

Authors:  Chatree Chai-Adisaksopha; Alfonso Iorio; Christopher Hillis; Wendy Lim; Mark Crowther
Journal:  BMC Hematol       Date:  2016-06-08

10.  Effect of Tropisetron on Prevention of Emergence Delirium in Patients After Noncardiac Surgery: A Trial Protocol.

Authors:  Yi Sun; Dandan Lin; Jing Wang; Mengwen Geng; Mei Xue; Yayun Lang; Lina Cui; Yanan Hao; Shanshan Mu; Dan Wu; Lirong Liang; Anshi Wu
Journal:  JAMA Netw Open       Date:  2020-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.